Does tirzepatide lower Leptin levels over time?
Yes—tirzepatide was linked to 44.4%–61.4% lower Leptin levels versus a dummy shot after 72 weeks.
Tirzepatide is a once-weekly medicine for type 2 diabetes and obesity. It belongs to GLP-1 Medications, medicines that act on hormone signals. Researchers took a fresh look at blood samples from the SURMOUNT-1 study. This analysis included 392 people with overweight or obesity who completed treatment. People had been assigned by chance to three doses or a dummy shot. Blood samples came from the start, week 24, and week 72.
Leptin showed a clear drop at all three doses. At 72 weeks, the differences versus the dummy shot were 44.4% for 5 milligrams, 59.3% for 10 milligrams, and 61.4% for 15 milligrams. These figures describe group-level changes compared with the dummy-shot group. They do not mean everyone had the same drop. Several other blood markers also improved, including measures of inflammation.
A lower result does not tell the whole story. Leptin comes from fat tissue and signals stored energy to the brain. Levels depend strongly on body fat and sex. One result cannot show whether the brain responds poorly to that signal. This analysis also does not prove that lowering Leptin itself prevents heart attacks.
For BioSocial members, the useful focus is change over time. Tracking Leptin alongside Weight, treatment dates, and dose changes can add context. Comparing notes with community peers can highlight different patterns without treating the study average as a personal target.
What changes have you seen in your Leptin results over time, and what else changed alongside them?

Comments
No comments yet.